These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6840893)

  • 1. Isotachophoretic pattern of LDH inhibiting fractions obtained from uremic ultrafiltrate by gelchromatography.
    De Smet R; van Landschoot N; van der Stiggel G; Ringoir S
    Int J Artif Organs; 1983 Mar; 6(2):67-70. PubMed ID: 6840893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
    Ringoir SM; van Landschoot N; de Smet R
    Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat.
    Anderstam B; Mamoun AH; Södersten P; Bergström J
    J Am Soc Nephrol; 1996 Nov; 7(11):2453-60. PubMed ID: 8959639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subfractions in uremic plasma ultrafiltrate inhibit calcitriol metabolism.
    Hsu CH; Vanholder R; Patel S; De Smet RR; Sandra P; Ringoir SM
    Kidney Int; 1991 Nov; 40(5):868-73. PubMed ID: 1762291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of middle molecule compounds.
    Zimmerman L; Jörnvall H; Bergström J; Fürst P; Sjövall J
    Artif Organs; 1981; 4 Suppl():33-6. PubMed ID: 7295092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of uremic ultrafiltrate using high resolution gas chromatography-mass spectrometry - identification of 6 polyphenols.
    Niwa T; Maeda K; Ohki T; Saito A; Kobayashi S; Asada H; Kobayashi K
    Clin Chim Acta; 1980 Nov; 108(1):113-9. PubMed ID: 7449132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic ultrafiltrate inhibits platelet-activating factor synthesis.
    Wratten ML; Tetta C; De Smet R; Neri R; Sereni L; Camussi G; Vanholder R
    Blood Purif; 1999; 17(2-3):134-41. PubMed ID: 10449871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of decreased calcitriol degradation in renal failure.
    Hsu CH; Patel SR; Young EW
    Am J Physiol; 1992 Feb; 262(2 Pt 2):F192-8. PubMed ID: 1311521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of uremic "middle molecular" fractions by gas chromatography, mass spectrometry, isotachophoresis, and liquid chromatography.
    Schoots AC; Mikkers FE; Claessens HA; De Smet R; Van Landschoot N; Ringoir SM
    Clin Chem; 1982 Jan; 28(1):45-9. PubMed ID: 7055936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nature of the inhibitors of lactate dehydrogenase in uremic dialysates.
    Wilkinson JH; Fujimoto Y; Senesky D; Ludwig GD
    J Lab Clin Med; 1970 Jan; 75(1):109-19. PubMed ID: 4378401
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of blood toxicity in chronic uremia by an improved chromatographic method.
    Politi L; D'Angelo AR; Caramia M; Molinaro M; Nicoletti R; Cerulli N; Moriggi M; Scandurra R
    Clin Exp Dial Apheresis; 1981; 5(3):277-84. PubMed ID: 7333038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Middle molecules in uremic serum, urine and dialysis fluid.
    Migone L; Dall'taglio P; Buzio C
    Clin Nephrol; 1975; 3(3):82-93. PubMed ID: 1139803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ion exchange chromatographic, gel filtration and isotachophoretic analysis of normal and uraemic sera.
    Menyhárt J; Gróf J
    Acta Chir Acad Sci Hung; 1981; 22(1-2):47-60. PubMed ID: 7345835
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence of splanchnic-brain signaling in inhibition of ingestive behavior by middle molecules.
    Mamoun AH; Södersten P; Anderstam B; Bergström J
    J Am Soc Nephrol; 1999 Feb; 10(2):309-14. PubMed ID: 10215330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of an immunosuppressive fraction in ultrafiltrate from uremic sera.
    Navarro J; Grossetete MC; Defrasne A; Touraine JL; Traeger J
    Nephron; 1985; 40(4):396-400. PubMed ID: 4022207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Na, K ATPase inhibitor from ultrafiltrate obtained by hemodialysis of patients with uremia.
    Sohn HJ; Stokes GS; Johnston H
    J Lab Clin Med; 1992 Aug; 120(2):264-71. PubMed ID: 1323635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent substances in uremic and normal serum.
    Shaykh M; Bazilinski N; McCaul DS; Ahmed S; Dubin A; Musiala T; Dunea G
    Clin Chem; 1985 Dec; 31(12):1988-92. PubMed ID: 4064287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of uremic middle molecules on the activity of erythrocyte lactate dehydrogenase (LDH)].
    Severini G; Malaguti-Aliberti L
    Ann Ist Super Sanita; 1985; 21(3):357-61. PubMed ID: 3834809
    [No Abstract]   [Full Text] [Related]  

  • 19. Analytical study for separation of middle molecules.
    Saito A; Kanazawa I; Chung TG; Maeda K
    Artif Organs; 1981; 4 Suppl():13-6. PubMed ID: 6975092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotachophoretic separation of middle molecule peptides in uremic body fluids.
    Zimmerman L; Baldesten A; Bergström J; Fürst P
    Clin Nephrol; 1980 Apr; 13(4):183-8. PubMed ID: 7379369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.